Liver diseases affect millions of people worldwide. In most developed countries, the
incidence of viral hepatitis is waning as a result of modern advances in disease prevention,
diagnosis, and therapies. Expanded programmes for systematic immunisation against
hepatitis B virus have also significantly brought down the number of new cases in many
countries, including China. In contrast, with the improvement in living standards, the
prevalence of metabolic liver diseases including non-alcoholic fatty liver disease and …